Jan 22, 2007 by Brian LawlerAnother Busy Year in Store for NovartisNew drugs might be on the way to help offset modest growth expected for this year.
Jan 19, 2007 by Brian LawlerThe Best Drug Stock for 2007: Endo PharmaceuticalsEndo just might be a great investment at the current price.
Jan 19, 2007 by Brian LawlerShould We Sweat Our Savings Rate?It's not the only measure of our retirement readiness.
Jan 17, 2007 by Brian LawlerDendreon in the Fast LaneThe FDA speeds up review of its leading drug candidate.
Jan 16, 2007 by Brian LawlerMedImmune's Improved Flu VaccineOne of the three most important traits for a drug's success is convenience in dosing.
Jan 12, 2007 by Brian LawlerGenentech on a Roll2006 was a great year for the world's largest biotech firm.
Jan 12, 2007 by Brian LawlerWhat's Next for Northfield Labs?It's still optimistic about its blood substitute despite disappointing trial results.
Jan 10, 2007 by Brian LawlerSeattle Genetics' Big DealA great collaboration agreement for a small biotech.
Jan 10, 2007 by Brian LawlerEndo's Plan to Bring In the DoughShares in the drug developer are worth a look.
Jan 9, 2007 by Brian LawlerPfizer's New Drug for Fat FidosSlentrol could help overweight and obese dogs slim down.
Jan 9, 2007 by Brian LawlerViroPharma's Healthy Sales GuidanceThe coming year looks like another strong one for the drug developer.
Jan 4, 2007 by Brian LawlerDueling Fools: 2007 BullGoing into 2006, there was much to be pessimistic about, but 2006 still turned out to be a good one.
Jan 4, 2007 by Brian LawlerDueling Fools: 2007 Bull RebuttalA weaker dollar, or even a stronger dollar, is not necessarily a bad omen for the U.S. economy and stock market
Jan 3, 2007 by Brian LawlerExelixis Busy Selling Its WaresExelixis inked another development deal with biopharma powerhouse Genentech.
Dec 29, 2006 by Brian LawlerNo Pain for AlexzaDecember's been good to lots of pharmas, but Alexza in particular has something to thank Santa for.
Dec 29, 2006 by Brian Lawler2006 in Review: CephalonThe drug developer had a great year, and it looks well-positioned for the future.
Dec 29, 2006 by Brian Lawler2006 in Review: GenzymeThe biopharma's biggest news this year was its acquisition of drug developer AnorMED.
Dec 29, 2006 by Brian LawlerAdams Tries to Fix Another CoughAdams Respiratory Therapeutics announced a new drug application filed.
